The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, first in human study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors.
 
Joshua Bauml
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Foundation Medicine; Genentech; Guardant Health; Inivata; Janssen; Merck; Novartis; Novartis; Regeneron; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Carevive Systems (Inst); Incyte (Inst); Janssen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
 
Natalie Sophia Grover
Stock and Other Ownership Interests - Sangamo Therapeutics
Consulting or Advisory Role - Kite, a Gilead company; Tessa Therapeutics
Research Funding - Genentech
(OPTIONAL) Uncompensated Relationships - Tessa Therapeutics
 
Amy Ronczka
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Daniel Cushing
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Michael Klichinsky
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Debora Barton
Employment - Carisma Therapeutics
Stock and Other Ownership Interests - Carisma Therapeutics
 
Elizabeth Claire Dees
Consulting or Advisory Role - G1 Therapeutics; Novartis (I); Strata Oncology
Research Funding - Bayer; Cerulean Pharma; Genentech/Roche; H3 Biomedicine; Lilly; Merck; Meryx Pharmaceuticals; Novartis; Pfizer
Travel, Accommodations, Expenses - G1 Therapeutics